---
title: "TD Cowen Remains a Buy on Waystar Holding Corp. (WAY)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294752060.md"
description: "TD Cowen analyst Charles Rhyee maintained a Buy rating on Waystar Holding Corp. (WAY) with a $42 price target. This follows a recent Buy from Citi, while Morgan Stanley previously held a Hold rating. Rhyee, covering healthcare stocks, has a 52.24% success rate."
datetime: "2026-08-04T00:55:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294752060.md)
  - [en](https://longbridge.com/en/news/294752060.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294752060.md)
generator: "portal-rs"
---

# TD Cowen Remains a Buy on Waystar Holding Corp. (WAY)

TD Cowen analyst Charles Rhyee maintained a Buy rating on Waystar Holding Corp. yesterday and set a price target of $42.00.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

Rhyee covers the Healthcare sector, focusing on stocks such as Cencora, Charles River Labs, and Icon. According to TipRanks, Rhyee has an average return of 5.0% and a 52.24% success rate on recommended stocks. 

In addition to TD Cowen, Waystar Holding Corp. also received a Buy from Citi’s Daniel Grosslight in a report issued yesterday. However, on July 30, Morgan Stanley maintained a Hold rating on Waystar Holding Corp. (NASDAQ: WAY).

### Related Stocks

- [WAY.US](https://longbridge.com/en/quote/WAY.US.md)
- [COR.US](https://longbridge.com/en/quote/COR.US.md)
- [CRL.US](https://longbridge.com/en/quote/CRL.US.md)
- [ICLR.US](https://longbridge.com/en/quote/ICLR.US.md)
- [C.US](https://longbridge.com/en/quote/C.US.md)
- [MS.US](https://longbridge.com/en/quote/MS.US.md)
- [C-R.US](https://longbridge.com/en/quote/C-R.US.md)
- [MS-O.US](https://longbridge.com/en/quote/MS-O.US.md)
- [MS-Q.US](https://longbridge.com/en/quote/MS-Q.US.md)
- [MS-E.US](https://longbridge.com/en/quote/MS-E.US.md)
- [MS-I.US](https://longbridge.com/en/quote/MS-I.US.md)
- [MS-L.US](https://longbridge.com/en/quote/MS-L.US.md)
- [MS-P.US](https://longbridge.com/en/quote/MS-P.US.md)
- [MS-A.US](https://longbridge.com/en/quote/MS-A.US.md)
- [MS-F.US](https://longbridge.com/en/quote/MS-F.US.md)
- [MS-K.US](https://longbridge.com/en/quote/MS-K.US.md)

## Related News & Research

- [Waystar Holding Corp. $WAY Shares Acquired by Janus Henderson Group PLC](https://longbridge.com/en/news/294602503.md)
- [Waystar: Strong Recurring Growth and Raised 2026 Guidance Underpin Daniels’ Buy Rating](https://longbridge.com/en/news/294276691.md)
- [Wedbush Keeps Their Buy Rating on IDEAYA Biosciences (IDYA)](https://longbridge.com/en/news/296510282.md)
- [88,309 Shares in UnitedHealth Group Incorporated $UNH Purchased by Allworth Financial LP](https://longbridge.com/en/news/296749626.md)
- [Alignment Healthcare to present at Baird 2026 Global Healthcare Conference](https://longbridge.com/en/news/296487994.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**